Editorials

Call for worldwide withdrawal of tiotropium Respimat mist inhaler

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7390 (Published 09 November 2012) Cite this as: BMJ 2012;345:e7390

Re: Call for worldwide withdrawal of tiotropium Respimat mist inhaler

We share the concerns of Duncan Petty and Toby Hillman regarding the illustration of the Handihaler device. The authors did not see or approve the illustration as it was not included in the electronic proofs.

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; RB received funding from Boehringer Ingelheim to present at a symposium; no other relationships or activities that could appear to have influenced the submitted work.

28 November 2012
Richard Beasley
Professor of Medicine
Sonal Singh, Yoon K Loke, Paul Enright, Curt D Furberg
Medical Research Institute of New Zealand
Private Bag 7902, Wellington 6242, NZ
Click to like:
41